← Product Code [GTQ](/submissions/MI/subpart-d%E2%80%94serological-reagents/GTQ) · K881209

# ASO SLIDE TEST (K881209)

_Ncs Diagnostics, Inc. · GTQ · Apr 12, 1988 · Microbiology · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/GTQ/K881209

## Device Facts

- **Applicant:** Ncs Diagnostics, Inc.
- **Product Code:** [GTQ](/submissions/MI/subpart-d%E2%80%94serological-reagents/GTQ.md)
- **Decision Date:** Apr 12, 1988
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 866.3720
- **Device Class:** Class 1
- **Review Panel:** Microbiology

## Regulatory Identification

Streptococcus spp. exoenzyme reagents are devices used to identify antibodies to Streptococcus spp. exoenzyme in serum. The identification aids in the diagnosis of disease caused by bacteria belonging to the genus Streptococcus and provides epidemiological information on these diseases. Pathogenic streptococci are associated with infections, such as sore throat, impetigo (an infection characterized by small pustules on the skin), urinary tract infections, rheumatic fever, and kidney disease.

---

**Source:** [https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/GTQ/K881209](https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/GTQ/K881209)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com